Biotech BP Architect

PassAudited by ClawScan on May 1, 2026.

Overview

This instruction-only skill is coherently focused on helping draft biotech fundraising decks while explicitly limiting use to authorized or public materials.

Before installing, make sure users only provide company-owned, authorized, or public materials. The skill appears suitable for drafting and reviewing biotech investor decks, but confidential scientific, patient, IP, licensing, or deal information should still be shared only when appropriate.